Which Laser Modalities And Treatment Parameters Are Recommended For Treating Acute (Striae Rubra) Versus Chronic (Striae Alba) Stretch Marks? Find The Right Laser For Your Practice

Match the laser to the stage of the stretch mark. Acute, red striae rubra are generally treated with vascular-targeted lasers, especially 585 or 595 nm pulsed-dye lasers, using conservative fluences around 2–4 J/cm² and larger 7–10 mm spot sizes. Chronic, white striae alba respond better to fractional resurfacing, such as 1,540–1,550 nm non-ablative fractional lasers or fractional CO₂ and Er:YAG systems, which target dermal remodeling rather than redness.

The key distinction is vascularity versus atrophy. Treat striae rubra primarily by reducing hemoglobin-related erythema; treat striae alba by creating controlled fractional thermal injury that stimulates collagen remodeling and improves texture. Exact settings must be adjusted for the device, skin phototype, lesion depth, and the patient’s response.

Why the Stage of the Striae Determines Treatment

Striae Rubra Are Vascular and Inflammatory

Striae rubra are early lesions with visible erythema and increased vascularity. Their red or violaceous appearance provides a chromophore, hemoglobin, that vascular lasers can selectively target.

The practical objective is usually reduction of redness, rather than complete restoration of normal skin structure.

Striae Alba Are Atrophic and Hypopigmented

Striae alba are older, pale lesions characterized by epidermal thinning, altered dermal collagen and elastin, and reduced pigmentation. They do not provide the same vascular target as striae rubra.

For this reason, vascular lasers generally have limited value for established striae alba. Their central problem is dermal atrophy and altered texture, not excess erythema.

Recommended Treatment for Striae Rubra

Preferred Modality: Pulsed-Dye Laser

A 585 or 595 nm pulsed-dye laser (PDL) is the most directly matched technology for red stretch marks. These wavelengths target oxyhemoglobin within superficial dermal vessels and can reduce the visible erythema.

Typical conservative parameters include:

Wavelength: 585 or 595 nm
Fluence: approximately 2–4 J/cm²
Spot size: approximately 7–10 mm
Pulse duration: device-dependent; protocols around 450 microseconds have been described for 585 nm systems
Sessions: often 1–2 treatments initially, with reassessment based on response

These values are starting ranges, not universal prescriptions. The device’s pulse structure, cooling system, skin phototype, and endpoint determine the final settings.

Why Larger Spot Sizes and Lower Fluences Matter

Larger spot sizes can provide appropriate penetration while treating a practical area efficiently. Conservative fluence helps reduce epidermal heating and the risk of post-inflammatory hyperpigmentation.

This precaution is particularly important in darker skin phototypes, where lower starting fluences, test spots, and careful sun protection may be necessary.

Alternative Vascular Approaches

Long-pulsed 1,064 nm Nd:YAG systems may be considered in selected cases, particularly when deeper vascular targeting or a different safety profile is desired. A described protocol uses approximately 2.5 mm spot sizes, 80–100 J/cm², 15–20 ms pulse delays, and 2 Hz repetition, with active cooling.

These Nd:YAG parameters are highly device-specific and should not be transferred to a different platform. They are also not interchangeable with the lower-fluence PDL ranges.

Intense pulsed light may also reduce erythema in suitable patients, but its broad spectrum makes careful selection of filters, fluence, pulse duration, and skin type essential.

Recommended Treatment for Striae Alba

Preferred Modality: Non-Ablative Fractional Laser

For chronic striae alba, a 1,540 or 1,550 nm non-ablative fractional laser, such as an erbium-doped fiber or Er:Glass system, is commonly preferred. The wavelength targets water in the skin and creates microscopic columns of controlled thermal injury.

The untreated surrounding tissue remains available for repair, allowing epidermal turnover and dermal collagen remodeling with generally less downtime than fully ablative resurfacing.

Example Non-Ablative Parameters

Published protocols describe ranges such as:

Pulse energy: approximately 35–55 mJ per microbeam with a 10 mm tip
Alternative tip configuration: approximately 12–14 mJ per microbeam with a 15 mm tip
Treatment course: commonly 2–6 sessions
Interval: approximately 2–4 weeks in some protocols

Other approaches use around 30 mJ, with 125–250 microthermal zones per cm², delivered over multiple passes. Because fractional platforms measure energy and density differently, these figures should be treated as examples of device-specific dosing rather than a universal recipe.

A conservative approach is preferable because striae extend into the upper-to-mid dermis and can behave similarly to atrophic scars. Some protocols recommend reducing the fluence by roughly 30% compared with standard acne-scar settings.

Fractional Ablative CO₂ and Er:YAG Lasers

Fractional ablative CO₂ and Er:YAG lasers remove microscopic columns of tissue while preserving intervening skin. They can produce stronger resurfacing and remodeling for deeper or more prominent striae.

The trade-off is greater erythema, discomfort, downtime, and pigmentary risk. These systems require particularly careful parameter selection in darker phototypes and in patients with a history of post-inflammatory hyperpigmentation.

What Fractional Treatment Can and Cannot Do

Fractional treatment can improve texture, atrophic depth, epidermal thickness, and the contrast between the striae and surrounding skin. It does not reliably recreate completely normal skin or restore every altered elastic fiber.

Clinical improvement is variable, and expectations should remain realistic. The supplementary evidence describes improvement that may be partial, with results commonly limited to a noticeable but incomplete change.

Understanding the Trade-offs

More Energy Does Not Necessarily Mean Better Results

Increasing fluence or density can increase thermal injury without proportionally improving the outcome. Excessive treatment may raise the risk of prolonged inflammation, burns, scarring, and post-inflammatory hyperpigmentation.

For striae, conservative treatment with adequate recovery time is generally more defensible than aggressive treatment based solely on energy escalation.

Non-Ablative and Ablative Systems Have Different Cost Profiles

Non-ablative fractional lasers usually offer less downtime and lower surface disruption, but they may require several sessions and produce gradual improvement.

Ablative fractional systems may offer more substantial remodeling per session, but they carry greater recovery demands and adverse-effect risks. The choice should account for lesion severity, skin type, tolerance for downtime, and the clinician’s experience.

Vascular Lasers Should Not Be Used as the Main Strategy for Alba

A vascular laser may reduce residual redness in a mixed or transitional lesion, but it is poorly matched to a purely white, atrophic stria alba. Treating chronic hypopigmented striae with vascular energy alone does not address the primary structural problem.

Mixed lesions may require staged treatment: vascular treatment for persistent erythema followed by fractional remodeling when appropriate.

Treatment Intervals and Aftercare Affect Safety

Fractional treatments are often spaced several weeks apart to allow inflammation and collagen remodeling to evolve. Depending on the platform and treatment intensity, intervals of approximately 4–6 weeks may be used for conservative remodeling protocols.

Topical anesthetic, forced-air or contact cooling, bland moisturization, and strict sun avoidance help manage discomfort and reduce pigmentary complications. Aftercare must follow the treating clinician’s device-specific instructions.

Making the Right Choice for Your Goal

Treatment should be selected after confirming the lesion’s color, age, depth, skin phototype, and the exact laser platform.

If your primary focus is reducing redness in early striae rubra: Consider a 585 or 595 nm pulsed-dye laser using a large spot size and conservative fluence, commonly around 2–4 J/cm².
If your primary focus is improving chronic white striae alba: Consider a 1,540–1,550 nm non-ablative fractional laser or a fractional CO₂ or Er:YAG laser for dermal remodeling.
If your primary focus is minimizing pigmentary risk: Use conservative energy, appropriate cooling, test spots when indicated, strict sun protection, and longer recovery intervals, particularly for darker skin phototypes.
If your primary focus is treating deep or mixed lesions: A staged plan may combine vascular treatment for persistent erythema with fractional remodeling for atrophy and texture.

The most reliable strategy is to treat the biological feature that dominates the lesion: vascular lasers for redness and fractional lasers for dermal atrophy.

Summary Table:

Stage of Stretch Marks	Recommended Laser	Wavelength/Type	Key Parameters	Treatment Sessions
Striae Rubra (Acute)	Pulsed-Dye Laser (PDL)	585 or 595 nm	Fluence: 2-4 J/cm², Spot: 7-10 mm, Pulse: ~450 µs	1–2 initial, reassess
Striae Alba (Chronic)	Non-Ablative Fractional Laser	1,540–1,550 nm	Pulse energy: 35-55 mJ (10 mm tip) or 12-14 mJ (15 mm tip)	2–6 at 2–4 week intervals
Striae Alba (Chronic)	Fractional Ablative (CO₂, Er:YAG)	10,600 nm / 2,940 nm	Device-specific; lower fluence by ~30% vs. acne scars	Varies, often 3–5 at 4–6 week intervals

Bring the latest laser technology to your clinic with BELIS. We specialize in professional-grade medical aesthetic devices, including diode, alexandrite, CO₂ fractional, Erbium, Nd:YAG, Pico, and more. Our solutions are designed to help you effectively treat stretch marks and a wide range of conditions, ensuring superior results for your patients. Contact us today at our contact form to discuss your specific needs and discover how our advanced equipment can elevate your practice.